By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
BOSTON, Dec. 7 NeuroPace, Inc. today announced that results from its pivotal trial demonstrated the RNS® System, a novel investigational device that utilizes responsive brain neurostimulation, significantly reduced the frequency ...
NEW ORLEANS and SUNNYVALE, Calif., Dec. 7 Pharmacyclics, Inc. (Nasdaq: PCYC) today announced interim data from a Phase I study of their novel orally administered Bruton's tyrosine kinase (Btk) inhibitor PCI-32765 in patients with relapsed ...
SAN DIEGO, Dec. 7 Ambit Biosciences Corporation announced today that preliminary results from a clinical trial of its lead product candidate, AC220, in acute myeloid leukemia (AML) were presented at the 51st Annual Meeting of the American ...
PARIS, December 7 - Very Positive 3-Year Results of the Long-Term Study Provide Confirmation of the Clinical Relevance of Oralair(R) Stallergenes S.A. today announces the 3-year results of a phase III clinical trial (VO53.06) to assess the ...
HOBOKEN, N.J., Dec. 7 Octapharma USA today announced the U.S. Food and Drug Administration has approved wilate® for the treatment of spontaneous and trauma-induced bleeding episodes in patients with all types of von Willebrand disease ...
ATLANTA, Dec. 7 A recent study presented at the Gerontological Society of America's 62nd Annual Scientific Meeting shows that a combination of vitamins and nutriceuticals improves memory and cognitive performance in community-dwelling ...
ANNAPOLIS, Md., Dec. 7 PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today announced Phase I clinical trial results for Protexia®, a pegylated recombinant ...
NEW YORK, Dec. 7 NeoStem, Inc. (NYSE Amex: NBS), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need and holds the exclusive, worldwide license to VSEL(TM) technology that ...
Response Rate Increases to 41% and Median Overall Survival Reported at 25 Months for All Evaluable Patients QUEBEC CITY, Dec. 7 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the "Company"), a global ...
UPPSALA, Sweden and EDISON, N.J., Dec. 7 Q-Med AB and Oceana Therapeutics, Inc. today announced that the SOLESTA(TM) pivotal study succeeded in meeting both primary endpoints for the treatment of fecal incontinence. Q-Med AB and ...
Researchers uncover how key enzymes team up to break down proteins, offering new insight into diseases like Alzheimer’s and certain cancers tied to protein mismanagement.
Discover how clapping is more than a social gesture—it's a complex scientific phenomenon involving rhythm, physics, and human connection across cultures.
Mindfulness and non-invasive brain stimulation show promise in reducing urinary incontinence by easing urgency triggers and improving bladder control.
UK health officials warn that summer travel may trigger a rise in measles cases, urging vaccination to prevent outbreaks.
New research reveals a connection between skin barrier issues and pediatric eosinophilic esophagitis, offering insight into potential causes and treatments.
Subscribe to our Free Newsletters!
Medindia's policies are aligned with the United Nations Sustainable Development Goals (SDGs) - SDG 3, SDG 4, SDG 5, SDG 6 , SDG 10 & SDG 12.
Disclaimer - All information and content on this site are provided for informational and educational purposes only. They should NOT be used for the diagnosis or treatment of any health-related condition or disease. Always consult a qualified healthcare professional for medical advice, diagnosis, or treatment. Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025
Careers